Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Older Age Increases Non-Relapse Mortality in Patients with Grade II–IV Acute Gvhd After Allogeneic Hematopoietic Cell Transplantation: A Retrospective Analysis of the Japanese Trump Database.

Takahiko Nakane, MD, PhD, Takahiro Fukuda, MD, PhD, Junya Kanda, MD, PhD, Shuichi Taniguchi, MD, PhD, Tetsuya Eto, MD, PhD, Kazuteru Ohashi, M.D., Yasuo Morishima, MD, PhD, Tokiko Nagamura, MD, PhD, Hisashi Sakamaki, MD, Yoshiko Atsuta, MD, PhD, Makoto Murata, MD, PhD

Blood (2012) 120 (21): 3095.

https://doi.org/10.1182/blood.V120.21.3095.3095

Published: 2012

Journal Articles

Intravenous Busulfan-Based Myeloablative Conditioning Is Comparable to TBI-Based Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Recipients with Acute Myeloid Leukemia: A Nationwide Retrospective Study From the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation

Takuya Yamashita, M.D., Ph.D., Takahiro Fukuda, MD, PhD, Shuichi Taniguchi, MD, PhD, Kazuteru Ohashi, M.D., Saiko Kurosawa, M.D., Yasuo Morishima, M.D., Tokiko Nagamura, MD, PhD, Hisashi Sakamaki, MD, Yoshiko Atsuta, MD, PhD, Akiyoshi Takami, MD, PhD, FJSIM

Blood (2012) 120 (21): 1922.

https://doi.org/10.1182/blood.V120.21.1922.1922

Published: 2012

Journal Articles

Gemtuzumab Ozogamicin After Allogeneic Stem Cell Transplantation for Acute Leukemia

Takeshi Kobayashi, MD, Naoki Shingai, MD, Shuntaro Ikegawa, MD, Yukie Takahashi, MD, Jun Aoki, MD, Kosuke Yoshioka, MD, Jinichi Mori, MD, Megumi Yasunaga, MD, Yoshio Umezawa, MD, Gaku Oshikawa, MD, Noriko Doki, MD, Kazuhiko Kakihana, MD, PhD, Kazuteru Ohashi, M.D., Hisashi Sakamaki, MD

Blood (2012) 120 (21): 1970.

https://doi.org/10.1182/blood.V120.21.1970.1970

Published: 2012

Journal Articles

Relative Increase of Lymphocytes As Early As 1 Month After Initiation of Dasatinib Is a Reliable Predictor for Achieving Complete Molecular Response At 12 Months in Chronic Phase CML Patients Treated with Dasatinib

Eri Matsuki, MD, PhD, Takashi Kumagai, MD, Koiti Inokuchi, MD, PhD, Kazuteru Ohashi, M.D., Atsushi Shinagawa, MD, PhD, Jin Takeuchi, MD, PhD, Chikashi Yoshida, MD, PhD, Shinichiro Okamoto, MD, PhD, Hisashi Wakita, MD, Yasuji Kozai, MD, Yukari Shirasugi, MD, Shin Fujisawa, MD, Osamu Iwase, MD, Shingo Yano, MD, Kaichi Nishiwaki, MD, Koji Oba, MD, Junichi Sakamoto, MD, Hisashi Sakamaki, MD

Blood (2012) 120 (21): 691.

https://doi.org/10.1182/blood.V120.21.691.691

Published: 2012

Journal Articles

Favorable Outcomes of Autologous Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in First Remission: On Behalf of the Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)

Harumi Kato, M.D., Takakazu Kawase, M.D., Shinichi Kako, M.D., Shuichi Mizuta, M.D., Kazuteru Ohashi, M.D., Mineo Kurokawa, M.D., Koji Iwato, M.D., Takehiko Mori, M.D., Ritsuro Suzuki, M.D., Hisashi Sakamaki, MD, Yasuo Morishima, M.D., Junji Tanaka, M.D.

Blood (2012) 120 (21): 2021.

https://doi.org/10.1182/blood.V120.21.2021.2021

Published: 2012

Journal Articles

Effects of Recipients’ Body Weight on Engraftment after Unrelated Bone Marrow Transplantation: Analysis of Clinical Data of 4065 Patients from the Database of the Japan Marrow Donor Program.

Takuya Yamashita, MD, Kazuteru Ohashi, M.D., Hideki Akiyama, M.D., Hisashi Sakamaki, M.D.

Blood (2007) 110 (11): 5083.

https://doi.org/10.1182/blood.V110.11.5083.5083

Published: 2007

NARROW

Older Age Increases Non-Relapse Mortality in Patients with Grade II–IV Acute Gvhd After Allogeneic Hematopoietic Cell Transplantation: A Retrospective Analysis of the Japanese Trump Database.

Gemtuzumab Ozogamicin After Allogeneic Stem Cell Transplantation for Acute Leukemia

Relative Increase of Lymphocytes As Early As 1 Month After Initiation of Dasatinib Is a Reliable Predictor for Achieving Complete Molecular Response At 12 Months in Chronic Phase CML Patients Treated with Dasatinib

Favorable Outcomes of Autologous Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in First Remission: On Behalf of the Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)

Effects of Recipients’ Body Weight on Engraftment after Unrelated Bone Marrow Transplantation: Analysis of Clinical Data of 4065 Patients from the Database of the Japan Marrow Donor Program.

Email alerts

ASH Publications

American Society of Hematology

Older Age Increases Non-Relapse Mortality in Patients with Grade II–IV Acute Gvhd After Allogeneic Hematopoietic Cell Transplantation: A Retrospective Analysis of the Japanese Trump Database.

Gemtuzumab Ozogamicin After Allogeneic Stem Cell Transplantation for Acute Leukemia

Relative Increase of Lymphocytes As Early As 1 Month After Initiation of Dasatinib Is a Reliable Predictor for Achieving Complete Molecular Response At 12 Months in Chronic Phase CML Patients Treated with Dasatinib

Favorable Outcomes of Autologous Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in First Remission: On Behalf of the Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)

Effects of Recipients’ Body Weight on Engraftment after Unrelated Bone Marrow Transplantation: Analysis of Clinical Data of 4065 Patients from the Database of the Japan Marrow Donor Program.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only